<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3822</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">http://dx.doi.org/10.31782/IJCRR.2021.131216</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Polypharmacy and Drug Interactions Study on Diabetic Patients of Geriatric Age Group at Rural Tertiary Care Hospital&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nagpure</surname><given-names>Shailesh</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kela</surname><given-names>Krishna</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dahiwele</surname><given-names>Akshay C.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>22</day><month>06</month><year>2021</year></pub-date><volume>2)</volume><issue/><fpage>39</fpage><lpage>43</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Polypharmacy is sometimes necessary but should be carried out with precautions when prescribing to the elderly age group. It may cause drug-drug interactions which can be dangerous and may land up into life-threatening situations. Aim: To study polypharmacy and drug-drug interactions among diabetic patients of the elderly age group at rural tertiary care hospital. Methodology: It was a cross-sectional study carried out at Acharya Vinoba Bhave Rural Hosptial, Sawangi, Wardha. Data were collected from case sheets of patients (n = 100) of either sex admitted to the hospital during the two months of study duration. Result: Patients between the age group 60__ampersandsignndash;69 years were the most common (65%) followed by 70 -79 years (26%) and 80 -89 years (9%) admitted to the hospital. The average number of drugs prescribed to 60 - 69 years, 70 __ampersandsignndash; 79 years and 80 - 89 years age group were 4.85, 4.63 and 3.09 respectively. Total 402 drugs were prescribed in 100 patients and a total of 239 drug-drug interactions was observed in the current study. Conclusion: Polypharmacy is a double-edged sword. Benefit-risk assessment always should be done before prescribing mul tiple drugs to elderly patients.&#13;
</p></abstract><kwd-group><kwd>Diabetes</kwd><kwd> Geriatric</kwd><kwd> Polypharmacy</kwd><kwd> Drug interactions</kwd><kwd> Adverse effects</kwd><kwd> Complications</kwd></kwd-group></article-meta></front></article>
